The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 9.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 37%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it strong buy, with a mean price target of $107.
AECOM
ACM · the NYSE · USD · Market cap $8.2B · 51,000 employees
AECOM, together with its subsidiaries, provides professional infrastructure consulting services for governments, businesses, and organizations internationally.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-11
Screened 2026-09-11 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
AECOM holds its Markup at $63.53. Consolidating, no directional conviction, held for 22 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 22 days |
| Price at the screen | $63.53 |
| Valuation | 22.37 trailing · 9.93 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.91 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 26.47% | Below 33% | Interest-bearing debt is just 26.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 33.47% | Below 49% | Money owed to the company is 33.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.39% | Below 5% | Only 0.4% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. A 66.9% margin of safety to the base estimate.
Third-party analyst targets: 12 covering, consensus Strong Buy. The average target sits +38% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCheap buildout stock or just another cycle trap
Governments keep pouring money into roads, rail and power grids, yet the firms that plan those projects rarely capture much of the upside. AECOM sits right in that middle layer, advising on projects worldwide while its own revenue inches forward just 1 percent a year and margins sit at 3 percent. The shares trade at 10.2 times forward earnings with a 29 percent return on equity, but the low multiple reflects a business that has never shown it can turn big infrastructure spend into sustained profit growth.
We pass because the numbers point to a classic cyclical value trap rather than a bargain. Revenue barely moves, margins stay thin, and the company operates in an industry where earnings peak just before the next slowdown arrives. Strong analyst targets and a clean ethical screen do not change the fact that the underlying growth engine remains weak.
The real risk sits in that revenue stagnation. Any dip in public spending or delay in large projects would quickly expose how little pricing power the business actually holds. Analysis, not advice.
| Forward P/E | 9.9xvery cheap relative to earnings |
| Trailing P/E | 22.4xa premium valuation |
| EPS, trailing | 2.84 |
| EPS, forward | 6.40 |
| Revenue growth | -14.2%revenue is shrinking |
| Profit margin | 1.9%barely profitable |
| Return on equity | 16.6%a solid return on shareholder capital |
| FCF yield | 4.65% |
| Dividend yield | 170.00% |
| Debt to equity | 1.39a meaningful debt load worth watching |
| Current ratio | 1.06adequate liquidity, worth monitoring |
| Beta | 0.91steadier than the market |
| Short interest, float | 0.06% |
| 52-week range | 60.35 - 135.52 |
| Market cap | $8.2B |
| Employees | 51,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeACM trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 37%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it strong buy, with a mean price target of $107.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 37%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it strong buy, with a mean price target of $107.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 37%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it strong buy, with a mean price target of $107.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $79.50 | -13.0% | · | $870 | -13.0% |
| 2 months | $83.59 | -17.3% | · | $827 | -17.3% |
| 3 months | $89.47 | -22.7% | $0.31 | $776 | -22.4% |
| 6 months | $99.29 | -30.4% | $0.62 | $703 | -29.7% |
| 1 year | $109.81 | -37.0% | $1.14 | $640 | -36.0% |
| 2 years | $83.98 | -17.7% | $2.10 | $848 | -15.2% |
| 3 years | $81.09 | -14.7% | $2.90 | $888 | -11.2% |
| 5 years | $61.93 | +11.7% | $3.86 | $1,179 | +17.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ACM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.